TuHURA Total Current Liabilities vs Non Currrent Assets Other Analysis
| HURA Stock | 5.93 0.75 11.23% |
TuHURA Biosciences financial indicator trend analysis is much more than just breaking down TuHURA Biosciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether TuHURA Biosciences is a good investment. Please check the relationship between TuHURA Biosciences Total Current Liabilities and its Non Currrent Assets Other accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in TuHURA Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.
Total Current Liabilities vs Non Currrent Assets Other
Total Current Liabilities vs Non Currrent Assets Other Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of TuHURA Biosciences Total Current Liabilities account and Non Currrent Assets Other. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between TuHURA Biosciences' Total Current Liabilities and Non Currrent Assets Other is -0.57. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of TuHURA Biosciences, assuming nothing else is changed. The correlation between historical values of TuHURA Biosciences' Total Current Liabilities and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of TuHURA Biosciences are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Total Current Liabilities i.e., TuHURA Biosciences' Total Current Liabilities and Non Currrent Assets Other go up and down completely randomly.
Correlation Coefficient | -0.57 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Total Current Liabilities
Total Current Liabilities is an item on TuHURA Biosciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of TuHURA Biosciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.Most indicators from TuHURA Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into TuHURA Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in TuHURA Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.As of December 11, 2024, Selling General Administrative is expected to decline to about 3.1 M. Issuance Of Capital Stock is expected to grow at the current pace this year
| 2023 | 2024 (projected) | Total Operating Expenses | 29.8M | 18.8M | Cost Of Revenue | 28.8K | 25.6K |
TuHURA Biosciences fundamental ratios Correlations
Click cells to compare fundamentals
TuHURA Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether TuHURA Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TuHURA Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tuhura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tuhura Biosciences Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in TuHURA Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TuHURA Biosciences. If investors know TuHURA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TuHURA Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of TuHURA Biosciences is measured differently than its book value, which is the value of TuHURA that is recorded on the company's balance sheet. Investors also form their own opinion of TuHURA Biosciences' value that differs from its market value or its book value, called intrinsic value, which is TuHURA Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TuHURA Biosciences' market value can be influenced by many factors that don't directly affect TuHURA Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TuHURA Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if TuHURA Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TuHURA Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.